MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Tandem Diabetes Care Inc

Closed

Sector Healthcare

30.97 -3.31

Overview

Share price change

24h

Current

Min

30.89

Max

31.29

Key metrics

By Trading Economics

Income

7.6M

-23M

Sales

141M

363M

EPS

-0.35

Profit margin

-6.4

Employees

2,400

EBITDA

7.3M

-17M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+66.45 upside

Dividends

By Dow Jones

Next Earnings

26 Feb 2025

Market Stats

By TradingEconomics

Market Cap

2.1B

Previous open

34.28

Previous close

30.97

News Sentiment

By Acuity

50%

50%

157 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Tandem Diabetes Care Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Mar 2024, 17:44 UTC

Major Market Movers

Tandem Diabetes Care Shares Drop 12% After Private Placement for Senior Notes

Peer Comparison

Price change

Tandem Diabetes Care Inc Forecast

Price Target

By TipRanks

66.45% upside

12 Months Forecast

Average 51.6 USD  66.45%

High 65 USD

Low 40 USD

Based on 5 Wall Street analysts offering 12 month price targets forTandem Diabetes Care Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 32.61Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

157 / 393 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.